Delaware Life NY Separate Account L has filed an amendment to its previous offering, which is significant for the company and its stakeholders. The amendment, filed on November 4, 2026, reflects the company’s ongoing commitment to compliance with federal regulations.

This filing is particularly relevant as it demonstrates Delaware Life's adherence to the provisions set forth under Rule 506(b) of the Securities Act. This rule provides a "safer harbor" for private offerings, allowing the company to continue its operations while ensuring that it meets regulatory standards.

Background

Delaware Life NY Separate Account L is categorized as a separate account under the jurisdiction of New York. The company has been active in the insurance industry, focusing on flexible premium variable life insurance and annuity contracts. Its recent filings indicate a history of compliance and updates, with the latest amendment being part of a series of filings dating back to at least 2011.

What the Filing Says

The recent amendment filing, accession number 0001104659-26-122604, includes details regarding the offering's compliance with federal exemptions such as 06b, 3C, and 3C.1. It also confirms that the company has not accepted investments from non-accredited investors, maintaining a focus on a select group of investors.

Impact

This filing may affect various stakeholders, including investors and regulatory bodies. The amendment indicates that Delaware Life NY Separate Account L is actively managing its offerings and ensuring that all necessary compliance measures are in place. The company has reported a total of four investors already involved in the offering, with a total amount sold of $155,371.

What's Next

The filing does not specify what happens next, leaving the future course of action open for the company. However, it is likely that Delaware Life will continue to monitor its compliance and potentially file further amendments as needed.